Ocuphire Pharma Stock Price and Value Analysis

Should you buy Ocuphire Pharma stock? (NASDAQ:OCUP). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Ocuphire Pharma to reach your target.

Target type
AdvantagesDisadvantagesNeutral
None.
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the OCUP Numbers

OCUP Price
(Ocuphire Pharma stock price per share)
$0.00
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drug Manufacturers - General stocks
[?] Free Cash Flow Jitter 44%

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Ocuphire Pharma Stock on Sale?

Based on our analysis, we believe that you should not buy Ocuphire Pharma right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy OCUP Stock?

Does Ocuphire Pharma have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

We don't yet have enough financial history for Ocuphire Pharma to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.